ECSP11010818A - Métodos para administrar formulaciones antifúngicas tópicas para el tratamiento de infecciones fúngicas - Google Patents
Métodos para administrar formulaciones antifúngicas tópicas para el tratamiento de infecciones fúngicasInfo
- Publication number
- ECSP11010818A ECSP11010818A EC2011010818A ECSP11010818A ECSP11010818A EC SP11010818 A ECSP11010818 A EC SP11010818A EC 2011010818 A EC2011010818 A EC 2011010818A EC SP11010818 A ECSP11010818 A EC SP11010818A EC SP11010818 A ECSP11010818 A EC SP11010818A
- Authority
- EC
- Ecuador
- Prior art keywords
- treatment
- formulations
- antifungical
- administer
- topic
- Prior art date
Links
- 206010017533 Fungal infection Diseases 0.000 title abstract 2
- 208000031888 Mycoses Diseases 0.000 title abstract 2
- 239000000203 mixture Substances 0.000 title 1
- 229940121375 antifungal agent Drugs 0.000 abstract 2
- 230000000843 anti-fungal effect Effects 0.000 abstract 1
- 150000002632 lipids Chemical class 0.000 abstract 1
- 239000004094 surface-active agent Substances 0.000 abstract 1
- 239000012049 topical pharmaceutical composition Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Molecular Biology (AREA)
- Emergency Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Dermatology (AREA)
- Biophysics (AREA)
- Organic Chemistry (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dispersion Chemistry (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US8311508P | 2008-07-23 | 2008-07-23 | |
| US10211108P | 2008-10-02 | 2008-10-02 | |
| US15018709P | 2009-02-05 | 2009-02-05 | |
| US16812209P | 2009-04-09 | 2009-04-09 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ECSP11010818A true ECSP11010818A (es) | 2011-05-31 |
Family
ID=41358304
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EC2011010818A ECSP11010818A (es) | 2008-07-23 | 2011-02-10 | Métodos para administrar formulaciones antifúngicas tópicas para el tratamiento de infecciones fúngicas |
Country Status (15)
| Country | Link |
|---|---|
| US (2) | US20100086504A1 (enExample) |
| EP (1) | EP2317993A2 (enExample) |
| JP (1) | JP2011529038A (enExample) |
| KR (1) | KR20110039357A (enExample) |
| CN (1) | CN102159202A (enExample) |
| AU (1) | AU2009275230A1 (enExample) |
| CA (1) | CA2731455A1 (enExample) |
| CL (1) | CL2011000135A1 (enExample) |
| CO (1) | CO6351719A2 (enExample) |
| EC (1) | ECSP11010818A (enExample) |
| IL (1) | IL210813A0 (enExample) |
| MX (1) | MX2011000932A (enExample) |
| NI (1) | NI201100025A (enExample) |
| PE (1) | PE20110642A1 (enExample) |
| WO (1) | WO2010010470A2 (enExample) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105125529A (zh) | 2007-02-05 | 2015-12-09 | 亲生物有限公司 | 烯丙胺药物化合物的增加的效力 |
| CA2751412A1 (en) * | 2009-02-05 | 2010-08-12 | Targeted Delivery Technologies Limited | Methods of reducing the proliferation and viability of microbial agents |
| FR2954163B1 (fr) * | 2009-12-18 | 2012-03-16 | Galderma Pharma Sa | Utilisation d'un tensioactif cationique, avantageu-sement amphotere, pour la preparation d'une composition antifongique applicable sur l'ongle |
| AU2010336441B2 (en) | 2009-12-23 | 2015-02-05 | Nuvo Research Inc. | Highly permeating terbinafine formulation for treating onychomycosis |
| PL2672962T3 (pl) | 2011-02-11 | 2015-08-31 | Moberg Pharma Ab | Nowa kompozycja przeciwgrzybicza |
| EP2688554A2 (en) * | 2011-03-21 | 2014-01-29 | Gregor Cevc | Optimised preparations of highly adaptable aggregates |
| WO2013057208A1 (en) | 2011-10-18 | 2013-04-25 | Targeted Delivery Technologies Limited | Compositions and methods for reducing the proliferation and viability of microbial agents |
| US8697753B1 (en) | 2013-02-07 | 2014-04-15 | Polichem Sa | Method of treating onychomycosis |
| CA2940494C (en) | 2014-03-14 | 2022-11-08 | Gojo Industries, Inc. | Hand sanitizers with improved aesthetics and skin-conditioning to encourage compliance with hand hygiene guidelines |
| AT516544B1 (de) | 2014-12-02 | 2017-05-15 | Universität Innsbruck | Stoffgemisch und Zubereitung |
| CN105193726B (zh) * | 2015-11-08 | 2018-01-26 | 长沙佰顺生物科技有限公司 | 一种治疗灰指甲的药物组合物 |
| US11554108B2 (en) * | 2016-08-29 | 2023-01-17 | Xeropedix, Inc. | Methods and compositions for treating cutaneous fungal infections |
| KR101952715B1 (ko) * | 2017-09-27 | 2019-02-27 | 경희대학교 산학협력단 | 천연 화합물을 포함하는 칸디다증 개선용 항진균 조성물 |
| JP7378401B2 (ja) * | 2018-01-02 | 2023-11-13 | サイネクシス，インコーポレーテッド | リポソームの中にカプセル化されたトリテルペノイド抗真菌薬の注射可能な組成物 |
| RU2698454C1 (ru) * | 2018-11-12 | 2019-08-27 | Федеральное государственное бюджетное образовательное учреждение высшего образования "Кубанский государственный медицинский университет" Министерства здравоохранения Российской Федерации (ФГБОУ ВО КубГМУ Минздрава России) | Способ лечения онихомикозов стоп |
| KR102072946B1 (ko) | 2019-08-06 | 2020-02-03 | 주식회사 씨엔엘바이오텍 | 조갑진균증 예방 또는 치료용 조성물 |
| JP2022552252A (ja) * | 2019-10-08 | 2022-12-15 | ハルクス，インコーポレイテッド | 爪真菌症治療用組成物及び方法 |
| AT524378A1 (de) | 2020-11-06 | 2022-05-15 | Univ Innsbruck | Zubereitung |
| KR20230116911A (ko) * | 2020-12-08 | 2023-08-04 | 모베르그 파르마 아베 | 알릴아민 항진균 조성물을 사용한 조갑진균증의 치료 요법 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CY1410A (en) * | 1979-08-22 | 1988-04-22 | Sandoz Ag | Propenylamines, processes for their production, pharmaceutical compositions containing them and their use as pharmaceuticals |
| US6005001A (en) * | 1991-05-20 | 1999-12-21 | Novartis Ag (Formerly Sandoz Ag) | Pharmaceutical composition |
| GB9111611D0 (en) * | 1991-05-30 | 1991-07-24 | Sandoz Ltd | Liposomes |
| EP1059941B1 (en) * | 1998-03-05 | 2004-05-26 | Phares Pharmaceutical Research N.V. | Pharmaceutical compositions and their use |
| US6383471B1 (en) * | 1999-04-06 | 2002-05-07 | Lipocine, Inc. | Compositions and methods for improved delivery of ionizable hydrophobic therapeutic agents |
| GB0108082D0 (en) * | 2001-03-30 | 2001-05-23 | Novartis Consumer Health Sa | Topical composition |
| US6846837B2 (en) * | 2002-06-21 | 2005-01-25 | Howard I. Maibach | Topical administration of basic antifungal compositions to treat fungal infections of the nails |
| US7473432B2 (en) * | 2002-10-11 | 2009-01-06 | Idea Ag | NSAID formulations, based on highly adaptable aggregates, for improved transport through barriers and topical drug delivery |
| WO2005087195A2 (en) * | 2004-03-18 | 2005-09-22 | Panacea Biotec Ltd. | Novel compositions for topical delivery |
| US20060078580A1 (en) * | 2004-10-08 | 2006-04-13 | Mediquest Therapeutics, Inc. | Organo-gel formulations for therapeutic applications |
| WO2006103638A2 (en) * | 2005-03-31 | 2006-10-05 | Ranbaxy Laboratories Limited | Topical pharmaceutical compositions of terbinafine and processes for their preparation |
| US20070077283A1 (en) * | 2005-09-30 | 2007-04-05 | Nastech Pharmaceutical Company Inc. | Method of enhancing transmucosal delivery of therapeutic compounds |
| JP5467722B2 (ja) * | 2007-01-16 | 2014-04-09 | ロート製薬株式会社 | 皮膚外用乳化製剤 |
| CN105125529A (zh) * | 2007-02-05 | 2015-12-09 | 亲生物有限公司 | 烯丙胺药物化合物的增加的效力 |
-
2009
- 2009-07-23 JP JP2011519254A patent/JP2011529038A/ja active Pending
- 2009-07-23 KR KR1020117004207A patent/KR20110039357A/ko not_active Withdrawn
- 2009-07-23 CA CA2731455A patent/CA2731455A1/en not_active Abandoned
- 2009-07-23 EP EP09786211A patent/EP2317993A2/en not_active Withdrawn
- 2009-07-23 PE PE2011000073A patent/PE20110642A1/es not_active Application Discontinuation
- 2009-07-23 CN CN2009801337541A patent/CN102159202A/zh active Pending
- 2009-07-23 US US12/508,537 patent/US20100086504A1/en not_active Abandoned
- 2009-07-23 AU AU2009275230A patent/AU2009275230A1/en not_active Abandoned
- 2009-07-23 WO PCT/IB2009/006742 patent/WO2010010470A2/en not_active Ceased
- 2009-07-23 MX MX2011000932A patent/MX2011000932A/es not_active Application Discontinuation
-
2010
- 2010-01-19 US US12/689,470 patent/US7820720B2/en not_active Expired - Fee Related
-
2011
- 2011-01-21 NI NI201100025A patent/NI201100025A/es unknown
- 2011-01-21 CL CL2011000135A patent/CL2011000135A1/es unknown
- 2011-01-23 IL IL210813A patent/IL210813A0/en unknown
- 2011-02-10 EC EC2011010818A patent/ECSP11010818A/es unknown
- 2011-02-15 CO CO11017742A patent/CO6351719A2/es not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| CO6351719A2 (es) | 2011-12-20 |
| JP2011529038A (ja) | 2011-12-01 |
| CL2011000135A1 (es) | 2011-09-23 |
| CA2731455A1 (en) | 2010-01-28 |
| WO2010010470A2 (en) | 2010-01-28 |
| US20100104633A1 (en) | 2010-04-29 |
| WO2010010470A3 (en) | 2010-03-18 |
| AU2009275230A1 (en) | 2010-01-28 |
| US7820720B2 (en) | 2010-10-26 |
| IL210813A0 (en) | 2011-04-28 |
| KR20110039357A (ko) | 2011-04-15 |
| CN102159202A (zh) | 2011-08-17 |
| PE20110642A1 (es) | 2011-08-31 |
| US20100086504A1 (en) | 2010-04-08 |
| NI201100025A (es) | 2011-11-02 |
| EP2317993A2 (en) | 2011-05-11 |
| MX2011000932A (es) | 2011-05-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NI201100025A (es) | Métodos de administración de las formulaciones tópicas antimicóticas para el tratamiento de las infecciones por hongos. | |
| CL2014003225A1 (es) | Composición que comprende un agente de control biológico y un fungicida. | |
| CO6602146A2 (es) | Uso combinado de proteínas cryda y cry1fa para el manejo de la resistencia de los insectos | |
| ECSP11011246A (es) | Métodos para reducir la proliferación y viabilidad de los agentes microbianos | |
| MX364978B (es) | Composiciones parasiticidas que comprenden un agente activo de isoxazolina, sus metodos y usos. | |
| MX380711B (es) | Composiciones veterinarias orales parasiticidas que comprenden agentes activos de accion sistemica, metodos y usos de las mismas. | |
| MX348079B (es) | Formulacion de isoxazolina topica localizada que comprende glucofurol. | |
| CR20160222U (es) | Formas solidas de acido { [ -(3- clorofenil) -3- hidroxipiridin -2-carbonil] amino} acetico, composiciones, y usos de las mismas | |
| MX2011011514A (es) | Formulaciones de canabidiol y metodos para utilizarlas. | |
| MX2015015506A (es) | Peptidos antimicrobianos. | |
| CO6460708A2 (es) | Composiciones borínicas | |
| BR112016006048A8 (pt) | composições antimicrobianas | |
| CL2014002348A1 (es) | Compuestos derivados de fenicol; composicion farmaceutica que los comprende; y su uso para controlar o tratar infecciones bacterianas en ganado. | |
| CL2011002675A1 (es) | Uso de compuestos derivados de nitrato o sulfato de 9-purin-9-il-3,4-dihidroxitetrahidrofuran-2-il-metilo para reducir la presion intraocular ; composicion farmaceutica oftalmica que comprende los compuestos; y formulacion oftalmica de uso topico que los comprende. | |
| CL2008002242A1 (es) | Compuestos derivados de n-cicloalquil-n-carboxamida, tiocarboxamida, biciclicas o derivados de carboximidamida n-sustituida; composicion fungicida; y metodo para controlar los hongos fitopatogenos de los cultivos. | |
| MX2015001348A (es) | Cocleatos hechos con fosfatidilserina de soja. | |
| MX385380B (es) | Formulacion topica para promover la curacion de heridas. | |
| MX2018007871A (es) | Composiciones para el cuidado personal. | |
| PE20150167A1 (es) | (r)-nifuratel, su uso para el tratamiento de las infecciones y sintesis de (r) y (s)-nifuratel | |
| AR083126A1 (es) | Composicion vacunal para el control de las infestaciones por ectoparasitos | |
| AR097599A1 (es) | Una composición que comprende extracto de guaçatonga y aroeira, su uso y un método para la prevención y/o tratamiento de señales causadas por el envejecimiento de la piel | |
| AR087790A1 (es) | Uso de un inhibidor de aromatasa para el tratamiento de hipogonadismo y enfermedades relacionadas | |
| BR112014001825A2 (pt) | lenço para a aplicação de pelo menos um princípio ativo sobre a pele | |
| CL2012001757A1 (es) | Compuestos derivados de 8-hidroxiquinolina-7-carboxamida; composicion farmaceutica; y su uso en el tratamiento de infecciones micoticas. | |
| CO7151497A2 (es) | Composiciones parasiticidas que comprenden derivados de benzimidazol, métodos y usos de los mismos |